Education:
Ph.D., 1988, University of Marburg, Germany
M.D., 1987, University of Marburg, Germany

Education:
Ph.D., 1988, University of Marburg, Germany
M.D., 1987, University of Marburg, Germany
Education:
Ph.D., University of Oklahoma
A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety of a candidate vaccine, BPL-1357, and its ability to prompt immune responses. The vaccine candidate was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID). The single-site trial can enroll up to 100 people aged 18 to 55 years and is led by NIAID investigator Matthew J. Memoli, M.D.
Submit a Media Request
Contact the NIAID News & Science Writing Branch.
Education:
D.V.M., 1993, Virginia-Maryland Regional College of Veterinary Medicine, College Park, MD